Selling And Administration Expenses Alterar Data
AbbVie USD 3.61B 273M 2023-12
Amgen USD 1.76B 424M 2023-12
AstraZeneca USD 3.91B 194M 2023-09
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Celldex Therapeutics USD 8.83M 611K 2023-12
CSL USD 1.29B 219.4M 2023-06
Dynavax Technologies USD 39.79M 2.63M 2023-12
Eli Lilly USD 1.92B 120.7M 2023-12
Gilead Sciences USD 1.61B 293M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
Incyte USD 293.86M 25.97M 2023-12
Intrexon USD 9.2M 120K 2023-09
J&J USD 5.81B 410M 2023-12
Jiangsu Hengrui CNY 2.34B 192.55M 2023-09
Merck EUR 1.42B 68M 2023-09
Merck USD 2.75B 272M 2023-12
Northwest Biotherapeutics USD 7.03M 534K 2023-09
Novavax USD 107.46M 25.24M 2023-09
Pfizer USD 4.47B 1.27B 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Rigel Pharmaceuticals USD 24.86M 1.45M 2023-09
Veracyte USD 49.06M 9.55M 2023-12



Agenus Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2024.